sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.
Cholangitis (primary sclerosing, PSC), with reimbursement 202
DOID EFO Endpoint Browser PheWeb
K11_CHOLANGI_STRICT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
30353 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
666 |
4. Check minimum number of eventsNone |
666 |
5. Include endpointsNone |
666 |
6. Filter based on genotype QC (FinnGen only) |
666 |
Control definitions (FinnGen only)
- Control exclude
- K11_IBD_STRICT_PSC
- Control conditions
- not K11_REIMB_202
Extra metadata
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- K83
- Name in latin
- Cholangitis
Similar endpoints
↥List of similar endpoints to
Cholangitis (primary sclerosing, PSC), with reimbursement 202
based on the number of shared cases.
Similar with more cases:
- Cholangitis (primary sclerosing, PSC)
- Reimbursement for rheumatic diseases
- Disorders of gallbladder, biliary tract and pancreas
- Gastrointestinal diseases
- Any reimbursement code in KELA
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2699 | 1491 | 1192 |
| Only index persons | 2473 | 1364 | 1109 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.03 |
| Only index persons | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 52.12 | 57.80 | 44.91 |
| Only index persons | 50.38 | 56.59 | 42.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 666 | 369 | 297 |
| Unadjusted period prevalence (%) | 0.13 | 0.13 | 0.13 |
| Median age at first event (years) | 45.25 | 49.06 | 40.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 602
- Matched controls
- 6021
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
291.9
323.0
353
29
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
323.0
602
*
A05AA02
ATC
ursodeoxycholic acid; oral
1326.8
323.0
496
21
K83.0
ICD-10 Finland
Cholangitis
4503599627370496.0
323.0
597
15
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
57.0
276.9
330
125
A07EC02
ATC
mesalazine; oral, rectal
41.3
250.1
324
165
K51.5
ICD-10 Finland
Left sided colitis
72.5
234.9
264
64
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
130.2
220.7
228
28
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
161.5
208.5
211
20
UJF30
NOMESCO Finland
Ileoscopy through colon
24.1
207.3
323
276
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
51.4
190.4
229
71
UJK02
NOMESCO Finland
ERCP
63.8
182.6
210
50
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
72.2
177.8
200
41
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
20.5
174.3
283
249
L04AX01
ATC
azathioprine; systemic
36.0
160.5
210
88
UJF32
NOMESCO Finland
Coloscopy
11.0
151.6
382
818
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
190.9
132.5
134
9
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
56.7
125.0
147
34
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
8.4
122.4
368
946
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
45.2
120.2
148
43
WX404
NOMESCO Finland
Intravenous generell anesthesy
8.5
117.5
334
773
K51.8
ICD-10 Finland
Other ulcerative colitis
60.4
107.5
125
26
A07EC01
ATC
sulfasalazine; oral, rectal
31.9
105.3
141
57
A07EA06
ATC
budesonide; oral, local oral
28.0
104.9
146
68
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
66.2
95.2
109
20
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.4
91.8
321
906
UJK12
NOMESCO Finland
Peroral cholangioscopy
178.1
88.8
91
6
K83.1
ICD-10 Finland
Obstruction of bile duct
62.1
85.5
99
19
WX402
NOMESCO Finland
General anaesthesia
6.6
85.0
272
667
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.9
82.2
215
393
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
280.5
74.2
74
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
276.2
73.1
73
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
38.5
72.4
92
28
J01MA12
ATC
levofloxacin; systemic
6.0
69.3
228
551
TPH04
NOMESCO Finland
Cathetrisation of vein
5.5
65.9
242
660
Z94.4
ICD-10 Finland
Liver transplant status
188.0
65.4
67
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
150.4
64.3
67
5
K50.8
ICD-10 Finland
Other Crohn disease
27.3
62.8
87
37
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
19.1
61.7
96
59
K76.9
ICD-10 Finland
Liver disease, unspecified
34.0
61.2
80
27
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.6
60.0
123
142
K50.1
ICD-10 Finland
Crohn disease of large intestine
45.9
59.8
73
18
JJC00
NOMESCO Finland
Allogenic transplantation of liver
217.5
58.1
59
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
613.5
57.6
56
*
P01AB01
ATC
metronidazole; oral, rectal
4.1
57.3
352
1544
K50.9
ICD-10 Finland
Crohn disease, unspecified
32.7
57.0
75
26
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
66.0
56.7
65
11
H02AB06
ATC
prednisolone; systemic
4.0
56.6
370
1709
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
47.0
55.1
67
16
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
193.2
51.8
53
*
WX002
NOMESCO Finland
Sedation and analgesia
4.6
51.1
213
634
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
100.7
50.8
55
6
J01MA02
ATC
ciprofloxacin; systemic
3.8
50.1
313
1341
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
68.4
49.2
56
9
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
55.9
47.7
56
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
47.5
328
1500
ZX120
NOMESCO Finland
Intravenous
6.1
45.6
136
273
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
49.3
45.0
54
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.1
44.9
135
273
L04AD01
ATC
ciclosporin; systemic
25.0
44.6
63
28
127
Kela drug reimbursment
Transplant complication
21.0
44.2
66
35
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
51.6
43.7
52
11
H02AB07
ATC
prednisone; oral
5.1
43.5
155
382
P01BA02
ATC
hydroxychloroquine; oral
11.4
43.0
83
83
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
17.4
42.0
67
43
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
34.7
41.8
54
17
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
154.0
41.3
43
*
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
19.5
39.3
60
34
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
37.9
38.8
49
14
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
13.6
38.0
67
55
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
36.8
35
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
32.5
36.7
48
16
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
378.8
36.4
36
*
A07EA02
ATC
hydrocortisone; rectal
14.6
36.3
62
47
L04AA06
ATC
mycophenolic acid; systemic
18.2
35.3
55
33
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
191.0
35.1
36
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
34.4
291
1431
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
69.3
34.4
39
6
H02AB04
ATC
methylprednisolone; systemic
4.3
34.1
143
407
K50.0
ICD-10 Finland
Crohn disease of small intestine
20.1
33.3
50
27
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
95.6
33.1
36
*
N02AX02
ATC
tramadol; systemic, rectal
2.9
32.5
301
1551
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.4
32.5
132
363
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
32.4
231
1002
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
76.2
32.2
36
5
R50.9
ICD-10 Finland
Fever, unspecified
3.9
32.1
152
480
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.5
31.8
87
152
L04AB04
ATC
adalimumab; parenteral
37.8
31.0
39
11
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
30.5
29
*
JJ5AT
NOMESCO Finland
NA
317.5
30.1
30
*
L01BB02
ATC
mercaptopurine; oral
21.5
30.0
44
22
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
112.4
30.0
32
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.7
29.1
89
179
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
18.2
28.4
44
26
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
44.9
28.0
34
8
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
294.4
28.0
28
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
7.6
26.2
63
91
L88
ICPC
Rheumatoid/seropositive arthritis
32.6
26.2
34
11
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
8.4
25.9
58
75
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
9.5
25.8
54
62
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
141.0
25.8
27
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.4
25.7
143
505
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
17.0
25.3
40
25
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
40.7
25.1
31
8
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
23.9
24.2
34
15
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
+∞
24.1
23
*
K51
ICD-10 Finland
Ulcerative colitis
19.0
23.8
36
20
L04AA01
ATC
[U] ciclosporin; systemic
21.1
23.3
34
17
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
23.2
23.2
33
15
K85.8
ICD-10 Finland
Other acute pancreatitis
56.4
23.2
27
5
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
67.7
23.0
26
*
A02BC02
ATC
pantoprazole; systemic
2.4
22.3
391
2641
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
26.2
21.9
30
12
L04AA13
ATC
leflunomide; oral
119.3
21.7
23
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.3
21.5
48
62
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
21.7
21.5
31
15
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
10.9
21.4
41
40
TK800
NOMESCO Finland
Hemodialysis
11.8
21.2
39
35
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
21.2
67
139
JJA20
NOMESCO Finland
Open biopsy of liver
43.3
20.6
25
6
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
15.8
20.4
33
22
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.4
20.4
45
57
C10AC01
ATC
colestyramine; oral
9.0
20.2
43
51
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.1
20.2
83
225
JN4CD
NOMESCO Finland
Very extensive body CT
7.2
20.0
49
73
K75.4
ICD-10 Finland
Autoimmune hepatitis
108.6
19.7
21
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
20.2
19.7
29
15
R94.5
ICD-10 Finland
Abnormal results of liver function studies
15.3
19.6
32
22
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
32.5
19.4
25
8
3AC01
NOMESCO Finland
NA
19.0
19.3
29
16
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
35.6
19.0
24
7
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
195.8
18.6
19
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
3.5
18.5
94
305
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.6
18.4
55
107
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
54.3
18.1
21
*
R4110
NOMESCO Finland
Physiotherapy
2.4
17.9
191
982
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
98.0
17.7
19
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
6.5
17.5
46
76
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.7
17.5
61
141
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
14.4
17.4
29
21
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
12.0
17.2
31
27
JAH00
NOMESCO Finland
Laparotomy
7.4
16.9
40
57
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
16.9
81
251
UJF92
NOMESCO Finland
Capsular endoscopy
8.6
16.7
36
44
M13.9
ICD-10 Finland
Arthritis, unspecified
5.4
16.7
51
102
M45
ICD-10 Finland
Ankylosing spondylitis
18.6
16.6
25
14
K83.3
ICD-10 Finland
Fistula of bile duct
174.6
16.6
17
*
WX419
NOMESCO Finland
Other general anesthesy
14.8
16.5
27
19
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
11.6
16.4
30
27
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
16.0
138
629
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
87.4
15.6
17
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.8
15.6
31
33
H02AB09
ATC
hydrocortisone; systemic
6.8
15.5
39
61
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
15.4
146
699
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
46.2
15.1
18
*
K85
ICD-10 Finland
Acute pancreatitis
11.2
15.1
28
26
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
14.8
104
420
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
+∞
14.6
14
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
153.5
14.5
15
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
153.5
14.5
15
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
14.4
83
294
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
3.1
14.2
84
302
WVA20
NOMESCO Finland
Medicine administration
6.8
14.1
35
54
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
30.8
13.9
18
6
C03DA01
ATC
spironolactone; oral
3.4
13.9
69
219
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.7
13.9
35
55
UJF02
NOMESCO Finland
Peroral enteroscopy
20.6
13.9
20
10
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.4
13.7
50
121
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
13.7
48
112
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
76.9
13.6
15
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
13.6
13
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
143.1
13.5
14
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
143.1
13.5
14
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.0
13.4
55
149
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
8.8
13.4
28
33
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
13.1
63
195
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
17.2
13.1
20
12
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
29.1
13.0
17
6
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
51.1
12.9
15
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
51.1
12.9
15
*
K92.1
ICD-10 Finland
Melaena
4.5
12.8
45
105
A02BC01
ATC
omeprazole; systemic
2.1
12.7
165
904
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
32.8
12.6
16
5
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
32.8
12.6
16
5
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
32.8
12.6
16
5
K81.0
ICD-10 Finland
Acute cholecystitis
11.3
12.6
23
21
D94
ICPC
Chronic enteritis/ulcerative colitis
17.8
12.6
19
11
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
12.5
12
*
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
13.5
12.5
21
16
JKA20
NOMESCO Finland
Cholecystectomy
6.7
12.5
31
48
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.2
12.5
48
123
A07EA01
ATC
prednisolone; rectal
14.7
12.3
20
14
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
27.3
12.1
16
6
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
66.2
11.6
13
*
1370
FHL
Colonoscopy, whole colon
19.4
11.6
17
9
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
11.4
11.6
21
19
M05BA04
ATC
alendronic acid; oral
3.5
11.6
54
164
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
4.7
11.5
39
88
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.5
11.5
55
170
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
11.5
11
*
M01CB01
ATC
sodium aurothiomalate; parenteral
+∞
11.5
11
*
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
122.2
11.5
12
*
K83
ICD-10 Finland
Other diseases of biliary tract
122.2
11.5
12
*
L04AC05
ATC
ustekinumab; parenteral
17.4
11.2
17
10
WX004
NOMESCO Finland
Patient-controlled sedation
14.2
11.0
18
13
JN4AD
NOMESCO Finland
Body CT examination
3.3
10.9
55
177
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.2
10.9
19
16
A09AA02
ATC
multienzymes (lipase, protease etc.)
8.5
10.9
23
28
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
15.9
10.9
17
11
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.3
10.9
28
46
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.3
10.6
54
176
L04AB01
ATC
etanercept; parenteral
111.9
10.4
11
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
10.4
10
*
L04AB06
ATC
golimumab; parenteral
+∞
10.4
10
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
10.4
142
786
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
10.4
213
1376
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.0
10.3
21
24
WX872
NOMESCO Finland
Intensive care
4.4
10.3
37
89
A41.9
ICD-10 Finland
Sepsis, unspecified
5.1
10.2
31
63
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
10.1
26
43
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
10.0
106
527
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
40.8
10.0
12
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
40.8
10.0
12
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
26.5
9.8
13
5
Z93.2
ICD-10 Finland
Ileostomy status
26.5
9.8
13
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
9.8
65
252
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.6
9.8
22
30
N02AA05
ATC
oxycodone; systemic
2.4
9.7
82
364
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
9.6
103
514
D97
ICPC
Liver disease NOS
30.5
9.4
12
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
30.5
9.4
12
*
B01AB05
ATC
enoxaparin; parenteral
1.9
9.4
166
1008
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
9.4
9
*
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
9.4
9
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
9.4
41
119
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.0
9.3
36
94
A41.8
ICD-10 Finland
Other specified sepsis
8.5
9.1
19
23
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
9.1
56
206
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.8
9.0
29
63
E0000UV
ATC
NA
1.7
8.8
233
1612
6611
FHL
Needle biopsy in the operating room
50.7
8.7
10
*
A07AA11
ATC
rifaximin; oral
50.7
8.7
10
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
50.7
8.7
10
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
11.8
8.6
15
13
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.5
8.5
29
67
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.7
8.5
36
102
4AA12
NOMESCO Finland
NA
20.4
8.5
12
6
JN4BD
NOMESCO Finland
Extensive body CT
2.5
8.5
66
279
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
91.3
8.4
9
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
91.3
8.4
9
*
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
91.3
8.4
9
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
91.3
8.4
9
*
K86.1
ICD-10 Finland
Other chronic pancreatitis
13.0
8.4
14
11
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
+∞
8.3
8
*
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
+∞
8.3
8
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
8.3
8
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
8.3
8
*
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
8.3
8
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
9.6
8.3
16
17
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
6.2
8.2
21
35
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
8.2
32
85
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
10.2
8.1
15
15
JLC30
NOMESCO Finland
Pancreatoduodenectomy
22.4
8.0
11
5
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.7
7.9
19
29
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
7.8
73
340
K86.8
ICD-10 Finland
Other specified diseases of pancreas
45.6
7.7
9
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
45.6
7.7
9
*
UJF30
SPAT
NA
18.6
7.6
11
6
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.7
7.6
32
91
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
25.4
7.6
10
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
10.2
7.6
14
14
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
7.5
86
439
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
7.5
60
258
WX892
NOMESCO Finland
Monitored bed care
2.6
7.5
52
209
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
81.0
7.4
8
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
7.8
7.4
16
21
K85.1
ICD-10 Finland
Biliary acute pancreatitis
13.6
7.4
12
9
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.5
7.4
15
18
5714B
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]
+∞
7.3
7
*
57505
ICD-8 Finland
Cholecystitis and cholangitis, without mention of calculus, Cholangitis alia sive NUD
+∞
7.3
7
*
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
+∞
7.3
7
*
JL5CM
NOMESCO Finland
Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet
+∞
7.3
7
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
7.3
7
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
7.3
7
*
K80.8
ICD-10 Finland
Other cholelithiasis
6.4
7.3
18
29
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.7
7.3
47
181
C03CA01
ATC
furosemide; systemic
1.9
7.2
117
685
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
30.4
7.2
9
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.7
7.1
46
177
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.1
7.1
18
30
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
8.9
7.1
14
16
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
7.1
25
61
K81.9
ICD-10 Finland
Cholecystitis, unspecified
10.2
7.1
13
13
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
10.2
7.1
13
13
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.1
7.0
16
23
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
7.0
60
268
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
6.9
60
271
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
6.9
84
440
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
6.9
30
88
WX882
NOMESCO Finland
High dependency care
3.6
6.9
29
83
XPX08
NOMESCO Finland
Intraoperative flow measurement
9.5
6.8
13
14
UJG02
NOMESCO Finland
Proctoscopy
5.8
6.8
18
32
RD210
NOMESCO Finland
NA
4.4
6.8
23
54
K74.0
ICD-10 Finland
Hepatic fibrosis
40.5
6.8
8
*
A11CC03
ATC
alfacalcidol; systemic
4.5
6.7
22
50
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
22.8
6.7
9
*
H26.3
ICD-10 Finland
Drug-induced cataract
22.8
6.7
9
*
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
22.8
6.7
9
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.0
6.6
17
29
J01DB01
ATC
cefalexin; oral
1.7
6.6
468
4075
M81.8
ICD-10 Finland
Other osteoporosis
12.4
6.6
11
9
ZX108
NOMESCO Finland
Inhalation
10.2
6.6
12
12
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
10.2
6.6
12
12
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
6.5
64
305
A07DA03
ATC
loperamide; oral
3.6
6.5
27
77
UJD02
NOMESCO Finland
Gastroscopy
3.1
6.5
33
110
RS220
NOMESCO Finland
NA
4.8
6.5
20
43
JJC60
NOMESCO Finland
Total excision of transplanted liver
70.5
6.4
7
*
L04AA11
ATC
[U] etanercept; parenteral
70.5
6.4
7
*
M06
ICD-10 Finland
Other rheumatoid arthritis
70.5
6.4
7
*
JFF10
NOMESCO Finland
Loop enterostomy
14.5
6.4
10
7
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
6.4
46
190
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
8.3
6.4
13
16
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
5.6
6.3
17
31
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
18.2
6.3
9
5
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
18.2
6.3
9
5
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
4.9
6.3
19
40
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
6.3
6
*
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
+∞
6.3
6
*
M01CB03
ATC
auranofin; oral
+∞
6.3
6
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
6.3
6
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
6.3
6
*
JFF13
NOMESCO Finland
Terminal enterostomy
27.0
6.2
8
*
S01AD03
ATC
aciclovir; ophthalmic
3.6
6.2
26
75
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.7
6.2
25
70
R11
ICD-10 Finland
Nausea and vomiting
2.5
6.1
47
201
4AB02
NOMESCO Finland
NA
12.7
6.1
10
8
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
12.7
6.1
10
8
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.7
6.1
12
14
Z94.0
ICD-10 Finland
Kidney transplant status
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
431
652
16.90
315.57
2.9
1.3
titre
594.1
507.1
0.35
157
112
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
409
586
16.50
310.77
13.3
2.8
umol/l
10.6
8.0
1.25
389
510
(3048689) Calprotectin [Mass/mass] in Stool
449
735
16.68
309.22
5.8
2.5
ug/g
171.2
122.9
2.02
401
597
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
422
184
60.87
307.65
7.6
3.2
u/ml
62.5
1648.6
0.99
390
156
(3007566) Smooth muscle Ab [Titer] in Serum
393
136
69.06
307.65
2.8
1.2
titre
71.6
65.0
0.19
37
12
(3005719) IgG [Mass/volume] in Serum or Plasma
439
399
30.35
307.65
4.6
2.3
g/l
12.2
9.9
17.18
428
363
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
314
44
134.13
307.65
2.8
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
190
29
91.27
307.65
2.3
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
296
150
34.72
307.65
2.8
1.5
titre
308.0
168.0
—
10
5
(3024980) IgG subclass 4 [Mass/volume] in Serum
325
90
69.57
307.65
3.3
1.5
g/l
0.8
0.7
0.41
297
71
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
232
41
86.30
307.65
1.8
1.2
titre
327.9
98.0
—
95
5
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
490
441
39.26
307.65
8.0
4.3
ug/l
2.9
16.7
0.82
391
365
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
458
467
29.20
307.65
7.2
2.4
g/l
0.2
0.2
3.11
451
437
(3028026) IgM [Mass/volume] in Serum or Plasma
413
324
31.92
307.65
3.3
1.6
g/l
1.4
1.3
0.24
400
298
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
360
490
14.81
280.19
6.4
2.4
u/l
47.0
130.3
0.40
352
415
(3022145) Colonoscopy Study observation
377
561
14.18
274.11
3.1
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
625
2013
35.19
231.94
21.1
4.9
g/l
35.7
36.4
2.59
620
1887
(3033658) Prothrombin time (PT) actual/Normal
508
1299
13.27
228.99
18.2
4.0
%
95.5
93.2
1.29
501
1270
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
585
1797
19.54
222.90
16.6
3.2
u/l
39.1
31.6
4.32
574
1716
(3032080) INR in Blood by Coagulation assay
566
1831
14.93
198.42
18.1
7.2
inr
1.1
1.2
1.37
176
557
(42870588) Differential panel, method unspecified - Blood
527
1681
11.23
182.33
15.1
5.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
440
1170
9.14
181.29
3.3
1.5
g/l
2.6
2.2
4.05
405
716
(3042936) Bacteria identified in Isolate by Culture
338
690
8.92
178.63
3.0
2.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
146
107
17.20
162.95
7.4
7.4
iu/ml
644.7
355.6
0.50
31
21
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
309
631
8.27
161.06
3.3
2.5
%
22.5
23.2
0.28
278
559
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
556
2093
11.03
155.37
5.3
2.3
nmol/l
75.4
75.1
0.07
548
1896
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
124
77
19.56
150.34
1.2
1.1
g/l
1.6
1.4
2.59
114
71
(3022948) Iron [Moles/volume] in Serum or Plasma
316
735
7.28
142.71
3.4
2.4
umol/l
12.7
13.8
1.32
308
684
(3004789) Transferrin [Mass/volume] in Serum or Plasma
301
679
7.26
139.83
3.4
2.4
g/l
2.4
2.4
0.46
294
639
(3022096) Basophils/100 leukocytes in Blood
569
2350
10.76
139.00
17.6
5.5
%
0.7
0.7
2.41
561
2201
(3006504) Eosinophils/100 leukocytes in Blood
573
2429
10.73
134.59
17.8
5.4
%
3.0
2.9
0.55
565
2269
(3006922) Hepatitis E virus Ab [Presence] in Serum
87
29
34.36
134.27
1.2
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
574
2447
10.74
133.69
18.1
5.6
%
8.9
8.5
2.76
567
2307
(3006315) Basophils [#/volume] in Blood
587
2576
11.78
132.14
17.7
5.3
e9/l
0.0
0.0
0.50
560
2217
(3001604) Monocytes [#/volume] in Blood
585
2566
11.52
131.46
17.6
5.3
e9/l
0.6
0.6
0.17
558
2211
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
90
38
27.23
128.15
7.3
2.3
%
92.2
98.7
0.54
90
38
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
82
27
34.49
126.89
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
82
27
34.49
126.89
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
591
2673
11.75
126.78
18.0
5.8
e9/l
0.2
0.2
0.02
564
2339
(3020779) Urea [Moles/volume] in Serum or Plasma
227
425
7.59
125.18
15.4
8.7
mmol/l
7.6
8.2
0.66
219
410
(3002030) Lymphocytes/100 leukocytes in Blood
573
2537
10.01
124.75
17.9
5.4
%
29.1
29.3
0.24
566
2386
(3018010) Neutrophils/100 leukocytes in Blood
568
2506
9.61
123.66
17.4
5.3
%
56.1
56.0
0.08
562
2364
(3019198) Lymphocytes [#/volume] in Blood
586
2665
10.98
123.63
17.8
5.4
e9/l
1.8
2.0
2.72
559
2349
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
196
327
8.08
119.90
2.6
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
404
1374
5.93
115.61
6.2
3.8
ph
7.4
7.4
1.93
83
256
(3026250) Tacrolimus [Mass/volume] in Blood
74
24
34.56
114.83
42.2
27.1
ug/l
6.8
7.6
0.74
67
18
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
435
1590
6.00
113.90
6.7
2.5
u/l
73.8
56.8
1.39
425
1486
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
536
2360
7.51
112.64
14.1
7.5
mmol/l
1.2
1.2
0.68
476
2024
(3013650) Neutrophils [#/volume] in Blood by Automated count
603
3000
11.68
109.93
21.8
8.7
e9/l
3.7
4.0
2.87
581
2609
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
68
20
37.75
108.43
5.0
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
423
1576
5.62
106.23
4.5
2.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
502
2176
6.31
104.41
12.6
6.9
mmol/l
1.2
1.2
0.39
488
1994
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
95
71
15.44
103.56
1.4
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
265
697
5.65
99.98
1.7
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
344
1168
5.02
94.38
4.2
2.2
mg/l
3.1
3.0
0.10
321
1002
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
115
138
9.86
91.47
1.7
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
111
128
10.21
90.96
1.6
1.6
u/ml
123.0
101.8
1.17
16
20
(3013826) Glucose [Moles/volume] in Serum or Plasma
566
2911
7.29
90.88
13.1
5.1
mmol/l
6.3
6.6
2.94
558
2710
(3042733) HLA Ab [Presence] in Serum
58
18
35.20
90.82
1.4
3.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
91
81
12.85
89.08
6.8
2.5
umol/l
29.7
7.8
4.00
82
57
(3023368) Bacteria identified in Blood by Culture
340
1193
4.78
88.22
8.6
4.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
116
148
9.28
87.84
1.5
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
497
2335
5.45
87.82
25.2
8.6
e9/l
0.0
0.0
0.50
456
1881
(3023183) Ammonium ion [Moles/volume] in Plasma
104
115
10.53
87.82
6.7
3.2
umol/l
34.8
35.1
0.05
94
97
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
113
141
9.45
87.06
1.5
1.6
u/ml
399.2
238.0
2.05
65
73
(4035726)
189
416
5.95
85.76
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
356
1316
4.66
85.72
13.5
6.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
284
895
4.79
83.96
1.8
1.7
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
73
51
15.95
82.19
1.2
1.2
u/l
45.8
55.8
0.91
54
35
(3013707) Erythrocyte sedimentation rate by Westergren method
631
3781
13.73
80.17
12.6
3.2
mm/h
17.1
10.6
18.68
622
3482
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
89
92
11.01
78.63
4.7
4.6
u/ml
1002.7
2371.6
—
9
12
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
119
185
7.61
75.81
1.3
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
51
20
27.53
73.86
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
51
20
27.53
73.86
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
85
95
10.11
70.83
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
61
40
16.69
70.82
3.6
1.6
g/l
0.8
1.1
3.08
61
40
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
90
114
8.97
68.04
1.9
1.6
iu/ml
0.0
0.0
0.41
29
17
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
616
3842
9.04
67.88
17.7
3.0
u/l
121.8
44.7
25.24
610
3642
(3003458) Phosphate [Moles/volume] in Serum or Plasma
220
659
4.49
67.53
11.2
7.0
mmol/l
1.1
1.1
0.07
215
619
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
183
475
4.93
67.37
3.3
4.8
u/l
225.2
235.0
0.66
178
458
(40768804) Tissue Pathology biopsy report
425
2026
4.03
66.87
3.3
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
458
2314
4.14
65.73
4.7
2.8
ug/l
109.0
108.5
0.01
445
2156
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
308
1199
3.92
65.14
4.2
2.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
63
51
13.54
64.97
1.5
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
64
57
12.32
62.18
2.0
1.3
g/l
0.5
0.4
0.72
38
42
(3028192) IgG subclass 2 [Mass/volume] in Serum
64
57
12.32
62.18
2.0
1.3
g/l
3.4
2.5
1.84
38
42
(3027135) IgG subclass 1 [Mass/volume] in Serum
64
57
12.32
62.18
2.0
1.3
g/l
9.2
6.2
3.51
39
42
(4062490)
64
57
12.32
62.18
2.0
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
456
2359
3.96
61.71
6.6
3.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
72
82
9.72
58.93
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
63
60
11.49
58.53
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
153
383
4.89
58.26
6.2
4.5
%
0.6
0.9
0.73
58
113
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
39
14
29.53
57.96
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
123
257
5.64
57.72
1.5
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
144
347
5.02
57.37
5.5
4.4
%
0.5
0.5
0.16
44
80
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
39
15
27.56
56.61
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
140
335
5.03
56.18
6.2
4.8
%
0.0
1.1
0.53
48
84
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
63
65
10.60
55.35
2.5
2.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
37
13
30.08
55.32
3.4
4.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
47
31
16.24
54.17
2.0
1.5
u/l
3.7
2.3
0.29
30
14
(3021879) Hepatitis B virus core Ab [Presence] in Serum
158
429
4.52
54.06
1.4
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
330
1484
3.43
53.44
4.9
3.0
e6/l
134.7
98.8
0.11
272
1130
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
51
42
13.07
51.87
1.1
1.0
mg/l
319.7
289.4
1.18
42
36
(3021440) Promyelocytes/100 leukocytes in Blood
140
358
4.69
51.54
6.4
4.6
%
0.0
0.1
1.60
56
101
(3018095) Leukocytes [#/volume] in Urine
357
1722
3.31
50.79
5.9
3.5
e6/l
16.0
104.6
2.78
281
1214
(40768797) Stomach Pathology biopsy report
203
698
3.74
49.63
1.5
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
302
1340
3.29
49.06
5.0
3.0
e6/l
0.2
0.5
1.99
250
997
(3000850) Epithelial cells [#/volume] in Urine
247
991
3.37
47.09
3.6
2.4
e6/l
5.3
6.1
0.30
224
869
(3027945) Reticulocytes/100 erythrocytes in Blood
165
509
3.98
47.01
4.7
3.6
%
1.9
1.8
0.79
156
468
(36304419) Bacteria [Presence] in Urine
294
1322
3.19
46.08
4.8
2.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
349
1735
3.13
45.83
5.0
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
212
786
3.49
45.71
3.8
2.9
e6/l
2.8
2.3
0.28
135
412
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
178
5.76
45.48
2.0
2.3
g/l
1.3
1.5
1.10
80
157
(3026782) Osmolality of Urine
237
945
3.34
45.39
3.7
2.6
mosm/kgh2o
557.4
550.0
0.19
217
810
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
110
6.99
43.50
1.3
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
37
28
13.93
39.39
7.0
1.3
umol/l
23.2
33.5
1.95
37
28
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
89
195
5.11
39.04
6.6
4.2
%
90.6
91.6
0.09
89
185
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
206
821
3.18
38.63
3.8
2.7
e6/l
0.7
1.1
1.49
129
445
(3021447) Carbon dioxide [Partial pressure] in Venous blood
152
503
3.62
38.47
10.8
5.3
kpa
5.8
5.8
0.19
147
495
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
192
736
3.26
38.43
2.5
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
151
498
3.63
38.41
10.8
5.4
mmol/l
0.9
1.7
1.80
133
400
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
147
477
3.67
38.31
3.5
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
126
370
3.97
37.95
3.5
3.4
e9/l
71.4
73.4
0.23
95
287
(3000991) Gas panel - Venous blood
143
460
3.69
37.72
17.8
9.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
76
7.64
36.96
5.3
3.2
%
55.7
56.2
0.06
54
76
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
127
394
3.75
35.20
3.1
2.4
ml/min/173m2
66.4
71.8
0.47
49
158
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
126
5.70
33.63
1.8
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
50
74
7.22
32.68
5.4
2.9
e9/l
4.2
4.5
0.24
50
74
(44816559) Phosphatidylethanol [Mass/volume] in Blood
65
127
5.56
32.28
1.5
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
27
17
16.51
31.59
3.8
6.4
mg/l
8.3
9.0
0.15
21
17
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
192
816
2.90
31.31
2.2
1.8
%
1.5
1.4
0.52
166
738
(3044889) 12 lead EKG panel
516
3574
2.97
31.20
4.1
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
112
349
3.66
30.62
5.3
3.8
mmol/l
1.2
1.2
0.04
106
308
(3036481) Cortisol [Moles/volume] in Serum or Plasma
140
505
3.24
30.37
2.9
2.0
nmol/l
342.0
367.8
0.84
134
469
(3026493) Urate [Moles/volume] in Serum or Plasma
245
1206
2.63
29.79
4.5
2.6
umol/l
2627.6
6318.0
1.06
233
1058
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
249
4.02
29.14
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
139
512
3.17
29.02
2.5
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
327
1862
2.49
28.98
2.4
1.8
pmol/l
94.3
97.5
0.53
192
938
(3022217) INR in Platelet poor plasma by Coagulation assay
136
498
3.18
28.66
17.6
18.1
inr
1.2
1.2
0.20
17
76
(40760892) CBC W Ordered Manual Differential panel - Blood
239
1184
2.59
28.45
10.0
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
138
516
3.11
28.02
2.5
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
654
5417
12.51
27.22
48.9
11.7
mg/l
17.9
22.3
5.13
628
4097
(3037467) Urinalysis macro (dipstick) panel - Urine
491
3448
2.61
26.43
6.6
3.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
120
5.10
25.97
3.9
5.4
u/ml
0.3
0.3
0.87
25
61
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
45
76
6.28
25.91
1.2
1.1
titre
96.0
—
—
5
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
45
77
6.20
25.57
1.0
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
40
61
6.91
25.37
3.9
3.1
%
1.0
1.7
0.81
35
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
80
226
3.89
25.06
16.5
14.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
230
1177
2.46
24.98
2.0
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
151
631
2.80
24.84
1.4
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
32
39
8.57
24.56
1.4
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
19
10
19.53
24.00
2.4
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
95
311
3.40
23.84
1.6
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
116
431
3.05
23.57
15.4
9.2
mmol/l
1.2
1.3
0.78
109
412
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
33
45
7.66
23.09
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
125
4.71
22.87
1.9
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
44
83
5.61
22.60
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
100
356
3.13
21.79
8.1
4.7
ng/l
95.7
78.2
0.81
95
325
(3035350) Ketones [Presence] in Urine by Test strip
370
2443
2.16
20.71
4.4
3.2
estimate
0.0
0.0
0.00
94
449
(3019309) Folate [Moles/volume] in Red Blood Cells
161
756
2.49
20.57
2.0
1.7
nmol/l
1216.0
1189.3
0.12
136
565
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
607
4981
3.47
20.31
36.5
10.7
ml/min/173m2
89.3
86.5
2.03
560
4032
(3021601) Nitrite [Presence] in Urine by Test strip
369
2452
2.13
20.09
6.3
4.4
estimate
0.0
0.0
0.50
96
460
(3052851) Hemolysis interference index of Serum or Plasma
56
144
4.15
19.88
3.9
2.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
371
2479
2.12
19.80
4.5
3.1
estimate
0.0
0.0
0.50
96
437
(3026008) Bacteria identified in Urine by Culture
236
1327
2.21
19.72
2.9
2.8
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
24
28
8.85
19.00
1.2
1.1
u/l
36.2
33.1
0.07
18
20
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
12
14.51
18.54
2.5
1.5
e6/l
11333.8
7103.4
—
9
5
(3003396) Base excess in Arterial blood by calculation
114
476
2.68
18.41
14.7
10.3
mmol/l
0.2
1.1
1.36
93
379
(3000494) Fungus identified in Specimen by Culture
132
604
2.48
17.60
2.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
198
1085
2.17
17.27
4.2
3.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
265
1627
2.04
17.06
4.3
3.2
mmol/l
2.3
2.4
2.08
244
1446
(3000570) Elastase.pancreatic [Mass/mass] in Stool
52
147
3.75
16.17
1.6
1.4
ug/g
209.8
317.0
2.47
34
89
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
9
25.20
16.09
4.6
3.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
13
12.59
16.08
2.6
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
249
1523
2.01
15.97
1.7
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
190
1053
2.13
15.92
2.1
1.5
nmol/l
19.7
21.0
0.63
181
901
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
150
3.68
15.71
1.9
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
200
1142
2.07
15.41
3.7
2.1
mg/l
1.8
1.2
1.33
168
862
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
21
8.78
14.19
1.1
1.1
miu/ml
1251.5
1482.7
0.40
18
21
(3004588) Protein electrophoresis panel - Serum or Plasma
70
260
2.89
14.00
2.0
2.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
8
24.39
13.85
1.8
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
220
1343
1.95
13.80
1.5
1.3
u/ml
1.0
1.2
0.30
53
357
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
154
3.43
13.68
1.9
1.7
ug/l
1.5
1.2
0.14
44
141
(40761511) CBC panel - Blood by Automated count
645
5762
4.79
13.57
35.4
10.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
607
5245
2.78
13.37
44.6
12.9
%
38.7
40.7
8.89
516
4120
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
36
6.29
13.00
2.2
2.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
37
96
4.02
12.96
3.4
3.2
mmol/l
1.6
2.8
2.42
24
64
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
55
5.07
12.73
1.3
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
70
274
2.74
12.68
19.3
11.9
%
0.6
0.7
1.21
70
274
(3020393) Adenovirus Ag [Presence] in Stool
15
16
9.57
12.59
1.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
76
4.37
12.58
1.8
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
609
5306
2.73
12.52
6.4
4.1
mmol/l
4.6
4.7
3.98
597
4970
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
19
8.60
12.41
1.2
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
13
12
11.03
11.99
5.6
4.0
%
54.7
47.9
0.30
13
12
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
69
276
2.67
11.98
19.3
11.8
%
1.3
1.4
0.98
69
276
(3051651) Icteric interference index of Serum or Plasma
22
40
5.65
11.71
4.5
2.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
118
3.54
11.69
1.8
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
94
441
2.32
11.62
11.7
5.0
kpa
5.2
4.8
0.84
89
431
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
56
4.79
11.50
3.1
3.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
8
20.45
11.17
2.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
11
11.09
11.09
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
47
159
3.10
11.06
7.1
8.3
%
1.7
1.6
0.16
47
149
(3051611) Lipemic interference index of Serum or Plasma
24
50
4.94
11.03
4.7
2.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
161
946
1.93
10.96
1.8
1.7
pmol/l
439.0
4994193.6
0.50
143
801
(3007930) Methemoglobin/Hemoglobin.total in Blood
46
155
3.11
10.90
7.3
8.5
%
0.9
0.9
0.10
46
146
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
129
3.32
10.86
2.4
2.0
g/l
13.5
10.1
2.52
36
115
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
17
8.39
10.64
1.4
1.1
%
39.6
43.3
—
7
11
(3000093) Morphology [Interpretation] in Blood Narrative
22
44
5.14
10.58
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
139
3.16
10.26
2.5
1.9
g/l
4.3
3.7
1.48
31
105
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
139
3.16
10.26
2.5
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
139
3.16
10.26
2.5
1.9
g/l
7.4
7.4
0.03
31
112
(3021788) Differential panel - Synovial fluid
24
54
4.57
10.09
2.0
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
488
4022
1.80
10.02
3.7
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
36
110
3.40
9.99
2.2
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
126
3.23
9.91
2.4
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
87
422
2.22
9.89
4.3
3.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
26
64
4.19
9.78
1.9
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
87
3.69
9.76
1.4
1.1
—
1.0
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
92
3.60
9.73
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
34
102
3.46
9.71
4.7
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
39
128
3.17
9.67
1.9
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
54
213
2.67
9.63
1.9
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
38
125
3.16
9.39
7.7
10.1
mmol/l
1.2
1.3
0.30
33
107
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
64
278
2.44
9.37
1.6
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
180
1147
1.78
9.28
2.7
3.4
ng/l
1215.7
957.4
0.51
159
959
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
111
3.27
9.17
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
111
3.27
9.17
1.8
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
146
883
1.84
8.91
4.0
3.7
ng/l
62.2
382.1
2.91
111
626
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
138
822
1.86
8.84
3.5
2.8
mmol/l
2.5
2.4
3.52
126
725
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
28
5.83
8.84
1.4
1.3
%
70.9
54.7
—
8
22
(3000475) Leukocytes [#/volume] in Synovial fluid
27
75
3.71
8.64
2.2
1.7
e6/l
6805.1
19884.1
1.00
18
56
(3007853) Bacteria identified in Skin by Aerobe culture
107
593
1.96
8.51
1.8
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
28
83
3.48
8.16
9.1
12.7
mmol/l
107.7
105.6
1.68
28
74
(3039000) Anion gap in Blood
28
83
3.48
8.16
9.1
12.7
mmol/l
11.6
11.4
0.15
28
74
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
27
5.66
8.05
1.1
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
27
5.66
8.05
1.1
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
27
5.66
8.05
1.1
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
89
3.36
8.02
1.8
3.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
132
2.91
7.98
2.6
2.0
g/l
3.3
3.1
0.44
31
108
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
28
5.46
7.76
1.1
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
28
5.46
7.76
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
28
5.46
7.76
1.1
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
57
3.96
7.75
2.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
204
1410
1.64
7.59
2.0
1.6
mmol/l
1.2
1.4
3.43
194
1213
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
15
7.44
7.57
1.5
1.3
ug/l
10.9
8.8
0.56
11
15
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
69
3.57
7.33
1.2
1.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
34
122
2.88
7.27
2.4
3.1
mg/l
39.3
93.9
0.55
23
100
(40767503) Oxygen content in Capillary blood by calculation
29
95
3.15
7.24
4.7
2.4
%
15.6
16.5
0.61
14
51
(3037121) Protein [Mass/volume] in Urine
45
188
2.49
7.18
3.8
4.0
g/l
0.1
0.2
1.65
33
92
(44806118)
23
66
3.57
7.04
2.3
1.7
—
—
—
0
0
(44790049)
23
66
3.57
7.04
2.3
1.7
—
—
—
0
0
(44790048)
23
66
3.57
7.04
2.3
1.7
—
—
—
0
0
(44790047)
23
66
3.57
7.04
2.3
1.7
—
—
—
0
0
(3019225) pH of Specimen
80
432
1.97
6.82
6.6
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
258
1928
1.55
6.75
4.6
3.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
200
1410
1.60
6.74
3.9
2.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
28
5.09
6.73
2.5
3.4
u/ml
1420.8
644.8
0.99
14
28
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
33
122
2.79
6.70
2.5
3.1
mg/l
28.5
29.1
0.06
22
99
(3024891) Influenza virus A+B Ag [Presence] in Specimen
43
184
2.43
6.53
1.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
70
3.37
6.47
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
70
3.37
6.47
1.7
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
70
3.37
6.47
1.7
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
184
1283
1.60
6.45
5.1
3.3
estimate
0.0
0.0
0.88
93
451
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
42
4.13
6.39
1.8
3.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
238
1764
1.54
6.38
4.2
3.2
ng/l
35.7
35.2
0.02
164
1113
(3011412) CD3 cells [#/volume] in Blood
20
56
3.65
6.36
1.9
3.1
e9/l
1.0
1.2
0.20
11
29
(3037756) Immunofixation for Serum or Plasma
25
82
3.13
6.25
1.5
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
133
2.64
6.21
6.5
2.7
mmol/l
23.5
24.8
0.85
28
119
(3003181) Sodium [Moles/volume] in Urine
24
78
3.15
6.10
1.5
1.5
mmol/l
48.6
70.0
1.40
16
69
(3008898) HLA-B27 [Presence]
45
203
2.30
6.09
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
95
2.92
6.00
1.5
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
69
3.26
5.92
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
69
3.26
5.92
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
39
168
2.40
5.86
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
36
4.24
5.85
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
97
2.86
5.79
1.9
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
70
3.22
5.79
1.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
81
3.04
5.74
5.0
3.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
202
2.26
5.73
1.2
1.3
miu/ml
280.3
224.7
0.38
16
95
(42529406) Shigella sp [Presence] in Stool by Culture
39
170
2.37
5.71
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
73
408
1.89
5.63
12.7
4.9
kpa
4.9
5.1
1.87
67
390
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
135
2.52
5.54
2.3
2.6
—
—
—
0
0
(3009343) pH of Capillary blood
72
404
1.88
5.49
12.8
4.9
ph
7.4
7.4
0.12
12
41
(3044941) Cell count panel - Synovial fluid
18
52
3.53
5.48
2.3
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
180
2.30
5.47
2.3
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
78
3.02
5.46
1.3
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
73
3.08
5.42
1.5
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
38
168
2.34
5.41
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
70
392
1.88
5.37
13.1
5.0
mmol/l
0.7
1.7
1.21
49
286
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
53
3.46
5.34
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
18
5.63
5.33
3.2
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
587
5384
1.76
5.32
5.7
4.5
mmol/l
2.6
2.8
9.51
570
5009
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.21
1.4
0.0
mg/l
1.8
—
—
5
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
562
5103
1.65
5.20
5.0
3.7
mmol/l
1.2
1.3
5.84
548
4751
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
54
3.40
5.19
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
50
253
2.06
5.13
6.4
6.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
6
13.47
5.09
1.4
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
55
3.34
5.06
2.1
1.8
pg
31.1
32.5
0.62
18
55
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
167
2.29
5.04
2.0
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
9
10.12
5.04
3.4
3.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
36
3.95
5.01
1.2
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
42
201
2.16
4.98
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
37
3.84
4.83
1.4
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
24
4.64
4.79
1.9
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
24
4.64
4.79
2.0
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
85
2.77
4.72
1.6
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
575
5286
1.64
4.64
5.5
4.0
mmol/l
1.5
1.4
4.67
562
4932
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
26
4.29
4.37
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
83
2.71
4.36
7.3
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
202
1548
1.44
4.28
3.7
3.3
mmol/l
7.2
8.1
1.89
189
1314
(3013512) EKG study
179
1341
1.46
4.27
4.1
3.5
—
—
—
0
0
(4281824)
15
46
3.31
4.21
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
52
3.13
4.11
1.3
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
23
4.40
4.10
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
63
2.91
4.09
1.7
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
8
10
8.08
4.07
9.5
8.5
mmol/l
20.6
25.4
—
8
10
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
42
3.38
4.06
2.0
3.3
%
7.4
11.4
—
9
30
(3041672) Baker's yeast Ab [Presence] in Serum
7
7
10.09
4.02
1.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
81
2.64
4.01
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
24
4.21
3.90
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
46
3.09
3.54
3.0
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
26
3.89
3.53
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
26
3.89
3.53
5.5
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
41
3.21
3.51
1.0
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
180
1394
1.40
3.50
2.3
2.1
u/l
160.1
220.5
0.43
175
1323
(3004451) EKG impression Narrative
9
18
5.05
3.38
1.8
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
38
205
1.91
3.33
3.7
3.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
90
2.38
3.27
1.2
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
7
8.63
3.27
1.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
52
313
1.72
3.21
14.2
5.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
15
5.38
3.20
1.1
1.3
—
—
—
0
0
(4268621)
15
56
2.72
3.07
2.5
2.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
34
3.27
3.07
1.5
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
48
287
1.72
3.04
3.5
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
57
2.67
2.98
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
58
2.62
2.89
1.4
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
13
5.43
2.87
1.1
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
9
6.71
2.87
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
9
6.71
2.87
3.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
52
325
1.65
2.82
1.2
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
18
4.48
2.80
1.9
2.1
ug/l
118.4
112.3
—
8
18
(3029075) Extractable nuclear Ab panel - Serum
8
18
4.48
2.80
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
350
1.62
2.78
3.7
2.6
e9/l
3.6
4.2
1.24
44
294
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
24
3.79
2.68
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
199
1.80
2.65
1.9
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
67
2.42
2.65
1.4
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
7
7.19
2.55
1.2
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
21
3.84
2.47
1.3
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
469
1.50
2.45
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
112
849
1.38
2.44
1.4
1.2
iu/ml
54.9
22.3
0.91
38
248
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
107
807
1.39
2.40
1.4
1.2
u/ml
10.7
2.0
0.78
40
317
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
8
6.29
2.37
1.4
2.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
52
2.53
2.37
2.1
2.4
e6/l
434.3
612.0
—
6
18
(4211845)
8
22
3.67
2.37
2.5
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
28
3.24
2.31
1.2
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
59
2.40
2.30
1.3
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
99
2.05
2.28
1.3
1.1
u/ml
5.5
2.5
—
6
47
(3041354) Potassium [Moles/volume] in Venous blood
12
47
2.58
2.28
2.8
2.6
mmol/l
4.1
4.0
0.31
12
47
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
23
3.51
2.27
1.9
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
23
3.51
2.27
1.9
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
18
3.92
2.25
1.1
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
86
2.12
2.24
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.2
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
54
2.44
2.21
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
161
1308
1.30
2.21
3.6
3.3
mg/l
810.0
323.2
0.43
105
862
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.3
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
166
0.36
2.17
1.2
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
61
2.32
2.16
1.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
49
2.48
2.11
1.4
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
10
5.03
2.07
5.0
2.7
u/l
218.8
5856.1
—
5
10
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
20
3.53
2.06
1.1
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
91
2.01
1.97
2.3
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
51
2.38
1.96
16.7
10.1
%
9.3
12.0
1.68
12
51
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
447
4132
1.25
1.95
4.4
3.8
pmol/l
14.7
14.6
0.08
415
3793
(3020682) Albumin/Creatinine [Ratio] in Urine
167
1384
1.28
1.95
4.2
4.1
mg/mmol
12.7
10.4
0.12
111
891
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
750
0.68
1.95
2.7
2.5
ug/l
0.8
0.7
0.17
31
411
(21494814) CD8 cells/100 lymphocytes in Specimen
5
11
4.57
1.94
1.6
1.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
27
2.99
1.94
2.3
1.7
u/l
16.9
13.5
—
8
27
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
78
2.08
1.92
1.5
1.3
u/ml
3.2
5.7
—
10
23
(1761868) Lipid panel - Serum or Plasma
181
2131
0.79
1.92
3.7
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
429
0.59
1.91
1.2
1.4
—
—
—
0
0
(3000492) Spirometry study
75
556
1.39
1.88
1.6
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
1.3
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
22
3.20
1.88
1.3
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
22
3.20
1.88
1.3
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
51
352
1.49
1.87
3.7
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
521
4918
1.27
1.81
5.0
4.5
mu/l
2.0
2.1
0.25
493
4551
(3035285) Chloride [Moles/volume] in Venous blood
11
47
2.36
1.78
2.9
2.6
mmol/l
105.3
105.6
0.08
11
47
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
47
2.36
1.78
2.9
2.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
30
2.69
1.73
1.3
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
17
90
1.91
1.66
5.3
2.9
mmol/l
1.4
1.5
0.27
17
90
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
19
3.18
1.66
1.8
2.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
127
1.76
1.66
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
44
621
0.69
1.62
1.3
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
583
0.68
1.57
1.7
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
21
2.87
1.51
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
1009
0.76
1.46
3.3
3.6
%
19.4
21.6
0.77
29
392
(40768806) Pleura Pathology biopsy report
9
38
2.39
1.46
1.6
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
28
2.52
1.45
2.3
3.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
28
2.52
1.45
2.3
3.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
66
1.99
1.44
1.8
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
22
2.74
1.43
1.7
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
46
2.19
1.40
1.4
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
17
96
1.79
1.40
20.2
6.2
%
62.7
64.8
0.14
17
96
(3003740) Influenza virus B Ag [Presence] in Specimen
21
127
1.67
1.38
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
567
0.70
1.37
8.9
6.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
15
82
1.85
1.36
5.7
3.1
mmol/l
7.6
7.5
0.04
15
82
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
17
2.96
1.36
1.4
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
17
2.96
1.36
3.0
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
173
0.51
1.31
1.6
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
6
24
2.51
1.30
1.7
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
53
696
0.74
1.30
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
34
2.37
1.29
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
16
264
0.60
1.24
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
116
1.66
1.22
21.2
6.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
19
2.64
1.22
1.6
2.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
38
2.12
1.18
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
167
1.52
1.14
1.7
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
176
1.50
1.12
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
532
5113
1.20
1.12
4.3
4.1
mmol/l
5.9
5.9
0.03
502
4707
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
104
1.65
1.10
5.2
3.4
mg/l
25.7
23.7
0.07
12
62
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
106
1.62
1.03
2.2
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
133
0.52
0.99
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
501
4815
1.16
0.93
6.5
5.1
mmol/mol
37.9
39.2
1.98
480
4519
(3023419) Bacteria identified in Sputum by Culture
10
55
1.83
0.92
1.8
2.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
87
1.62
0.88
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
213
1.38
0.86
1.4
1.5
u/l
8.7
8.3
0.03
22
170
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
113
1.52
0.83
2.6
2.7
ug/min
52.2
118.3
—
8
77
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
46
1.75
0.82
2.3
4.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
338
0.73
0.80
2.2
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
48
1.67
0.79
1.0
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.1
—
18.4
—
0
20
(3041806) Other cells [#/volume] in Blood by Manual count
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
115
1.49
0.77
5.2
4.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
99
1.53
0.76
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
37
289
1.30
0.75
1.3
1.5
iu/l
33.1
23.7
0.64
29
238
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
60
1.68
0.72
1.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
40
1.76
0.71
1.9
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
101
1.50
0.70
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
284
0.73
0.69
1.3
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
27
1.86
0.68
2.2
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
59
1.53
0.68
1.1
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
1.9
1.3
mg/l
3.2
3.1
—
7
42
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
140
1261
1.14
0.68
1.6
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
428
0.78
0.68
2.2
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
412
1.23
0.68
1.1
1.3
iu/ml
151.9
152.7
0.00
14
175
(3039443) Prostate specific Ag panel - Serum or Plasma
7
121
0.57
0.67
1.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
180
1.35
0.66
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
51
1.58
0.60
1.6
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
122
1.40
0.60
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.3
—
2.7
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
29
364
0.79
0.58
1.2
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
341
0.78
0.57
1.3
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
230
1.27
0.56
2.5
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
37
1.63
0.55
2.3
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
61
1.48
0.54
2.3
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
93
835
1.13
0.49
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
366
0.81
0.49
1.3
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
366
0.81
0.49
1.3
2.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
111
0.63
0.48
2.3
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
360
0.83
0.43
1.3
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
122
1.32
0.42
1.1
2.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
27.8
—
0
15
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
1.7
—
0
11
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
117
1266
0.91
0.41
3.6
4.0
ug/l
1.7
1.9
0.28
110
1158
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.8
—
17.0
—
0
17
(4094501)
17
132
1.30
0.40
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
121.3
—
0
11
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
762
1.12
0.40
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
205
1.23
0.40
2.0
2.5
u/l
65.4
4934.0
—
10
87
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
61
1.32
0.39
1.1
1.1
%
86.5
98.6
—
8
56
(3015183) Erythrocyte sedimentation rate
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
89.4
—
0
14
(3020891) Body temperature
21
170
1.24
0.37
4.4
5.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
29
342
0.84
0.36
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
45
1.34
0.34
1.3
2.2
ug/l
19.5
19.0
—
6
45
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
777
0.90
0.32
1.9
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
110
1.28
0.32
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
55
1.28
0.30
1.0
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
112
1.26
0.28
1.1
1.1
—
12.7
—
0
9
(3019150) Specific gravity of Urine by Refractometry
118
1114
1.07
0.26
5.4
3.4
kg/l
1.0
1.0
0.05
19
143
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
71
0.70
0.26
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
80
857
0.92
0.24
2.0
2.1
—
—
—
0
0
(4027681)
5
39
1.28
0.23
1.4
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
42
381
1.11
0.22
1.5
1.2
u/ml
127.9
233.7
0.80
37
354
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
273
0.87
0.22
1.6
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
363
1.11
0.21
1.9
2.3
ug/l
1.8
7.5
6.76
31
330
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
1.2
—
0
6
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
3.1
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
2.5
—
0
5
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
43
1.16
0.21
1.0
1.1
—
1.2
—
0
6
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
43
1.16
0.21
1.4
1.1
nmol/l
0.8
1.3
—
5
38
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
0.7
—
0
7
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
7
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
165
0.85
0.19
1.6
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
165
1.16
0.19
1.3
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
15
128
1.18
0.18
1.3
2.0
e6/l
27.5
228.9
—
10
100
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
15
128
1.18
0.18
1.3
2.0
e6/l
4.0
7.2
—
7
97
(4010399)
33
362
0.91
0.18
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
62
1.13
0.17
1.1
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
68
1.18
0.16
1.4
2.8
—
—
—
0
0
(4306422)
9
81
1.11
0.15
1.1
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
139
0.86
0.14
1.1
1.1
u/ml
6.4
5.4
—
6
89
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
148
0.88
0.12
1.2
1.2
u/ml
9.0
3.0
—
6
75
(3019832) Treponema pallidum Ab [Presence] in Serum
59
620
0.95
0.12
2.0
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
126
0.87
0.11
1.6
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
23
211
1.09
0.11
1.8
1.8
nmol/l
62.0
36.1
2.33
23
203
(3011288) Drugs identified in Urine by Screen method
23
250
0.92
0.11
1.2
2.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
54
1.11
0.09
2.7
3.4
u/ml
140.2
71.2
—
6
54
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
146
1.10
0.08
1.3
2.0
mg/l
413.7
428.3
0.09
16
137
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
236
0.93
0.08
2.1
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
72
0.83
0.07
2.3
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
1.5
1.2
ug/l
2.7
2.9
—
6
65
(3049717) Cytology report of Urine Cyto stain
16
147
1.09
0.07
2.8
2.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
122
0.90
0.07
1.5
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
92
0.87
0.06
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
128
1.10
0.06
1.4
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
132
0.91
0.06
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
34
325
1.05
0.06
1.9
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
152
0.92
0.06
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
152
0.92
0.06
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
121
0.91
0.06
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
344
0.96
0.05
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
455
1.04
0.05
2.0
2.3
nmol/l
16.8
13.6
1.36
41
418
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
151
0.93
0.05
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
151
0.93
0.05
1.6
1.4
—
—
—
0
0
(4034850)
15
158
0.95
0.02
7.7
8.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
182
1.05
0.02
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
208
0.96
0.02
1.7
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
134
1.05
0.00
1.3
1.9
mmol/l
3.7
3.7
0.09
14
125
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
614
1.01
0.00
3.6
4.1
%
36.4
30.9
4.18
52
422
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
91
0.99
0.00
1.3
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
37.2
—
0
5
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
60
1.00
0.00
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
11.5
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
80
1.00
0.00
1.3
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
83
0.96
0.00
1.9
1.9
—
1680.0
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.4
—
0.6
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.0
1.3
nmol/l
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
8
0.00
-0.00
0.0
1.4
—
91.3
—
0
8
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.4
—
2.0
—
0
8
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_CHOLANGI_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CHOLANGI_STRICT | 2.908 [2.29, 3.7] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.435 |
During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 1127 females with K11_CHOLANGI_STRICT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CHOLANGI_STRICT | 2.237 [1.71, 2.93] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 180 out of 971 males with K11_CHOLANGI_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have K11_CHOLANGI_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.293% | 0.479% |
| 5 | 1.856% | 2.601% |
| 10 | 4.805% | 6.542% |
| 15 | 8.555% | 12.088% |
| 20 | 14.957% | 19.247% |
Relationships between endpoints
↥Index endpoint: K11_CHOLANGI_STRICT – Cholangitis (primary sclerosing, PSC), with reimbursement 202
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data